Diabetic neuropathy: Is pain god's greatest gift to mankind?

Seminars in Vascular Surgery

Volumn 25, Issue 2, 2012, Pages 61-65

  Boulton, Andrew J M ^a,b,c,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Manchester Royal Infirmary ^*

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d European Association for the Study of Diabetes   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETIC FOOT; DIABETIC NEUROPATHY; DIABETIC PATIENT; HUMAN; LEG; MEDICAL DEVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; PLANTAR ULCER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSORY DYSFUNCTION; TOTAL CONTACT CAST; WEIGHT BEARING;

ASYMPTOMATIC DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; HUMANS; MASS SCREENING; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84864056034     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2012.04.009     Document Type: Article

References (28)

1. Boulton A.J.M. Diabetic foot: what can we learn from leprosy?. The legacy of Dr Paul W Brand. Diabet Metab Res Rev 2012, 28(suppl 1):3-7.
2. Boulton A.J.M., Malik R.A., Arezzo J., et al. Diabetic somatic neuropathies: a technical review. Diabetes Care 2004, 27:1458-1486.
3. Boulton A.J.M., Gries F.A., Jervell J.A. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Med 1998, 15:508-514.
4. Boulton A.J.M., Malik R.A. Diabetic neuropathy. Med Clin N Am 1998, 82:909-929.
5. Kumar S., Ashe H.A., Parnell L.N., et al. The prevalence of foot ulceration and its correlates with type 2 diabetic patients: a population-based study. Diabet Med 1994, 11:480-484.
6. Intensive blood glucose with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352:837-853. UK Prospective Diabetes Study.
7. Abbott C.A., Vileikyte L., Williamson S., et al. Multi-centre study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998, 7:1071-1075.
8. Ward J.D. The diabetic leg. Diabetologia 1982, 22:141-147.
9. Andersen H. Motor dysfunction in diabetes. Diabet Metab Res Rev 2012, 28(suppl 1):89-92.
10. Boulton A.J.M., Armstrong D.G., Albert S.F., et al. Comprehensive foot examination and risk assessment: a report of the Taskforce of the Foot Care Interest group of the American Diabetes Association. Diabetes Care 2008, 31:1679-1685.
11. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
12. Reiber G.E., Vileikyte L., Boyko E.J., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157-162.
13. Rayman G., Vas P.R., Baker N., et al. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 2011, 34:1517-1518.
14. Bowling F.L., Harris W.E., Abbott C.A., et al. Vibratip: a pocket-sized device for testing the integrity of sensation in the outpatient setting. Diabet Med 2012 Jun 4, [Epub ahead of print]. 10.1111/j.1464-5491.2012.03730.x.
15. Argiana V., Eleftheriadou I., Tentolouris N. Screening for the high risk foot at risk of ulceration: tests of autonomic and somatic nerve function. Curr Diab Rep 2011, 11:294-301.
16. Game F.L., Chipchase S.Y., Hubbard R., et al. Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant 2006, 21:3207-3210.
17. Ndip A., Lavery L.A., Lafontaine J., et al. High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapy. Diabetes Care 2010, 33:878-880. 2010.
18. Ndip A., Rutter M.K., Vileikyte L., et al. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 2010, 33:1811-1816.
19. Boulton A.J.M., Vinik A.I., Arezzo J.C., et al. Diabetic neuropathy: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962.
20. International Working Group on the diabetic foot: guidelines. Diabet Metab Res Rev 2012, 28(suppl 1):119-237.
21. Armstrong D.G., Nguyen H.C., Lavery L.A., et al. Offloading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001, 24:1019-1022.
22. Boulton A.J.M., Vileikyte L., Kirsner R.S. Neuropathic diabetic foot ulcers. N Engl J Med 2004, 351:48-55. 2004.
23. Wu S.C., Jensen J.L., Weber A.K., et al. Use of pressure offloading devices in diabetic foot ulcers: do we practice what we preach?. Diabetes Care 2008, 31:2118-2119.
24. Armstrong D.G., Lavery L.A., Kimbriel H.R., et al. Activity patterns of patients with diabetic foot ulcers: patients with active ulcers may not adhere to a standard pressure offloading regimen. Diabetes Care 2003, 26:2595-2597.
25. Katz I.A., Harlan A., Miranda-Palma B., et al. A randomized trial of two irremovable offloading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005, 28:555-559.
26. Nabuurs-Franssen M.H., Sleegers R., Huijberts M.S., et al. Total contact casting of the diabetic foot in daily practice: a prospective study. Diabetes Care 2005, 28:243-247.
27. Jeffcoate W.J. Charcot neuroarthropathy. Diabet Metab Res Rev 2008, 24(suppl 1):S62-S65.
28. Ndip A., Williams A., Jude E.B., et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic neuroarthropathy. Diabetes 2011, 60:2187-2196.